Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinazoline derivatives as tyrosine kinase inhibitors

Quinazoline derivatives as tyrosine kinase inhibitors

US Patent 8735410 · Granted May 27, 2014

Estimated economic value: $22,522,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-pip2024
Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-pip2024
Dendrimer formulations2024
Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-pip2024
Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibito2024
Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-pip2024
Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibito2023
Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-pi2023
Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibito2021
Pyrazole derivatives useful as 5-lipdxygenase activating protein (FLAP) inhibito2019
Quinazoline derivatives as VEGF inhibitors2019
Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibito2019